Genetron Health to Participate in Upcoming Investor Conferences
January 31 2022 - 8:00AM
Genetron Holdings Limited (“Genetron Health” or the “Company”,
Nasdaq: GTH), a leading precision oncology platform company in
China that specializes in offering molecular profiling tests, early
cancer screening products and companion diagnostics development,
today announced that management will be participating in two
upcoming virtual investor conferences.
Sizhen Wang, co-founder and CEO, and Evan Xu,
Chief Financial Officer, will participate in a fireside chat on
Wednesday, February 16, 2022 at 8:00am EST and conduct investor
meetings February 15-16, 2022 at the virtual BTIG MedTech, Digital
Health, Life Science & Diagnostic Tools Conference.
Management will also participate in investor
meetings February 17-18, 2022 at the virtual 11th Annual SVB
Leerink Global Healthcare Conference.
About Genetron Holdings
LimitedGenetron Holdings Limited (“Genetron Health” or the
“Company”) (Nasdaq: GTH) is a leading precision oncology platform
company in China that specializes in cancer molecular profiling and
harnesses advanced technologies in molecular biology and data
science to transform cancer treatment. The Company has developed a
comprehensive oncology portfolio that covers the entire spectrum of
cancer management, addressing needs and challenges from early
screening, diagnosis, and treatment recommendations, as well as
continuous disease monitoring and care. Genetron Health also
partners with global biopharmaceutical companies and offers
customized services and products. For more information, please
visit https://ir.genetronhealth.com/.
Investor Relations ContactUS:Hoki LukHead of
Investor RelationsEmail: hluk@genetronhealth.us Phone: +1
(408) 891-9255
Philip Trip TaylorPrinciple | Gilmartin GroupEmail:
ir@genetronhealth.com
Genetron (NASDAQ:GTH)
Historical Stock Chart
From May 2024 to Jun 2024
Genetron (NASDAQ:GTH)
Historical Stock Chart
From Jun 2023 to Jun 2024